{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:23:09Z","timestamp":1765380189063},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00105-019-4378-8","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T17:13:25Z","timestamp":1552497205000},"page":"260-264","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dermatitis herpetiformis"],"prefix":"10.1007","volume":"70","author":[{"given":"H. A.","family":"Juratli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"G\u00f6r\u00f6g","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"S\u00e1rdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"issue":"1","key":"4378_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","volume":"54","author":"S Husby","year":"2012","unstructured":"Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R et al (2012) European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J\u00a0Pediatr Gastroenterol Nutr 54(1):136\u2013160. \n                    https:\/\/doi.org\/10.1097\/MPG.0b013e31821a23d0","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"4378_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2133.2011.10385.x","volume":"165","author":"TT Salmi","year":"2011","unstructured":"Salmi TT, Hervonen K, Kautiainen H, Collin P, Reunala T (2011) Prevalence and incidence of dermatitis herpetiformis: a\u00a040-year prospective study from Finland. Br J Dermatol 165(2):354\u2013359. \n                    https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10385.x","journal-title":"Br J Dermatol"},{"issue":"8","key":"4378_CR3","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00105-008-1679-8","volume":"60","author":"M Sardy","year":"2009","unstructured":"Sardy M, Tietze J (2009) Dermatitis herpetiformis. An update of the pathogenesis. Hautarzt 60(8):627\u2013632. \n                    https:\/\/doi.org\/10.1007\/s00105-008-1679-8","journal-title":"Hautarzt"},{"issue":"2","key":"4378_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.iac.2012.04.005","volume":"32","author":"S Karpati","year":"2012","unstructured":"Karpati S (2012) An exception within the group of autoimmune blistering diseases: dermatitis herpetiformis, the gluten-sensitive dermopathy. Immunol Allergy Clin North Am 32(2):255\u2013262. \n                    https:\/\/doi.org\/10.1016\/j.iac.2012.04.005","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"4378_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/003655202753387356","volume":"37","author":"K Hervonen","year":"2002","unstructured":"Hervonen K, Hakanen M, Kaukinen K, Collin P, Reunala T (2002) First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol 37(1):51\u201355","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"4378_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1399-0039.1997.tb02706.x","volume":"49","author":"A Spurkland","year":"1997","unstructured":"Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E (1997) Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens 49(1):29\u201334","journal-title":"Tissue Antigens"},{"issue":"2","key":"4378_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1152\/physrev.00019.2013","volume":"94","author":"RL Eckert","year":"2014","unstructured":"Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GV et\u00a0al (2014) Transglutaminase regulation of cell function. Physiol Rev 94(2):383\u2013417. \n                    https:\/\/doi.org\/10.1152\/physrev.00019.2013","journal-title":"Physiol Rev"},{"issue":"5","key":"4378_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.smim.2015.11.001","volume":"27","author":"J Stamnaes","year":"2015","unstructured":"Stamnaes J, Sollid LM (2015) Celiac disease: Autoimmunity in response to food antigen. Semin Immunol 27(5):343\u2013352. \n                    https:\/\/doi.org\/10.1016\/j.smim.2015.11.001","journal-title":"Semin Immunol"},{"issue":"11","key":"4378_CR9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00105-006-1235-3","volume":"57","author":"C Pfeiffer","year":"2006","unstructured":"Pfeiffer C (2006) Dermatitis herpetiformis. A clinical chameleon. Hautarzt 57(11):1021\u20131028. \n                    https:\/\/doi.org\/10.1007\/s00105-006-1235-3\n                    \n                   (quiz 1029)","journal-title":"Hautarzt"},{"issue":"6","key":"4378_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.20011299","volume":"195","author":"M Sardy","year":"2002","unstructured":"Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N (2002) Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J\u00a0Exp Med 195(6):747\u2013757","journal-title":"J Exp Med"},{"issue":"2","key":"4378_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/jid.2014.368","volume":"135","author":"TB Taylor","year":"2015","unstructured":"Taylor TB, Schmidt LA, Meyer LJ, Zone JJ (2015) Transglutaminase 3 present in the IgA aggregates in dermatitis herpetiformis skin is enzymatically active and binds soluble fibrinogen. J\u00a0Invest Dermatol 135(2):623\u2013625. \n                    https:\/\/doi.org\/10.1038\/jid.2014.368","journal-title":"J Invest Dermatol"},{"issue":"1","key":"4378_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jdermsci.2016.07.005","volume":"84","author":"A Gorog","year":"2016","unstructured":"Gorog A, Nemeth K, Szabo L, Mayer B, Sillo P, Kolev K et\u00a0al (2016) Decreased fibrinolytic potential and morphological changes of fibrin structure in dermatitis herpetiformis. J\u00a0Dermatol Sci 84(1):17\u201323. \n                    https:\/\/doi.org\/10.1016\/j.jdermsci.2016.07.005","journal-title":"J Dermatol Sci"},{"issue":"8","key":"4378_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/exd.13449","volume":"27","author":"S Karpati","year":"2018","unstructured":"Karpati S, Sardy M, Nemeth K, Mayer B, Smyth N, Paulsson M et\u00a0al (2018) Transglutaminases in autoimmune and inherited skin diseases: The phenomena of epitope spreading and functional compensation. Exp Dermatol 27(8):807\u2013814. \n                    https:\/\/doi.org\/10.1111\/exd.13449","journal-title":"Exp Dermatol"},{"issue":"8","key":"4378_CR14","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.jid.2016.03.039","volume":"136","author":"A Gorog","year":"2016","unstructured":"Gorog A, Nemeth K, Kolev K, Zone JJ, Mayer B, Sillo P et al (2016) Circulating Transglutaminase 3\u2011immunoglobulin A immune complexes in dermatitis Herpetiformis. J\u00a0Invest Dermatol 136(8):1729\u20131731. \n                    https:\/\/doi.org\/10.1016\/j.jid.2016.03.039","journal-title":"J Invest Dermatol"},{"issue":"3","key":"4378_CR15","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1111\/bjd.15995","volume":"178","author":"M Hietikko","year":"2018","unstructured":"Hietikko M, Hervonen K, Salmi T, Ilus T, Zone JJ, Kaukinen K et al (2018) Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of patients with dermatitis herpetiformis after a\u00a0long-term gluten-free diet. Br J Dermatol 178(3):e198\u2013e201. \n                    https:\/\/doi.org\/10.1111\/bjd.15995","journal-title":"Br J Dermatol"},{"issue":"7","key":"4378_CR16","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.4049\/jimmunol.1003273","volume":"186","author":"JJ Zone","year":"2011","unstructured":"Zone JJ, Schmidt LA, Taylor TB, Hull CM, Sotiriou MC, Jaskowski TD et al (2011) Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology. J\u00a0Immunol 186(7):4474\u20134480. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1003273","journal-title":"J Immunol"},{"issue":"1","key":"4378_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaad.2008.12.037","volume":"61","author":"C Rose","year":"2009","unstructured":"Rose C, Armbruster FP, Ruppert J, Igl BW, Zillikens D, Shimanovich I (2009) Autoantibodies against epidermal transglutaminase are a\u00a0sensitive diagnostic marker in patients with dermatitis herpetiformis on a\u00a0normal or gluten-free diet. J\u00a0Am Acad Dermatol 61(1):39\u201343. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2008.12.037","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"4378_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-2001-11147","volume":"39","author":"G Oberhuber","year":"2001","unstructured":"Oberhuber G, Caspary WF, Kirchner T, Borchard F, Stolte M (2001) Study group of gastroenterological pathology of the German society of pathology. Recommendations for celiac disease\/sprue diagnosis. Z\u00a0Gastroenterol 39(2):157\u2013166. \n                    https:\/\/doi.org\/10.1055\/s-2001-11147","journal-title":"Z Gastroenterol"},{"issue":"6","key":"4378_CR19","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1365-2133.2012.11105.x","volume":"167","author":"K Hervonen","year":"2012","unstructured":"Hervonen K, Alakoski A, Salmi TT, Helakorpi S, Kautiainen H, Kaukinen K et al (2012) Reduced mortality in dermatitis herpetiformis: a\u00a0population-based study of 476 patients. Br J Dermatol 167(6):1331\u20131337. \n                    https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11105.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"4378_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00403-013-1409-7","volume":"306","author":"G Wozel","year":"2014","unstructured":"Wozel G, Blasum C (2014) Dapsone in dermatology and beyond. Arch Dermatol Res 306(2):103\u2013124. \n                    https:\/\/doi.org\/10.1007\/s00403-013-1409-7","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"4378_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/jamadermatol.2016.4676","volume":"153","author":"LN Albers","year":"2017","unstructured":"Albers LN, Zone JJ, Stoff BK, Feldman RJ (2017) Rituximab treatment for recalcitrant dermatitis Herpetiformis. Jama Dermatol 153(3):315\u2013318. \n                    https:\/\/doi.org\/10.1001\/jamadermatol.2016.4676","journal-title":"Jama Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-4378-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-019-4378-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-4378-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:10:27Z","timestamp":1583885427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-019-4378-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4378"],"URL":"https:\/\/doi.org\/10.1007\/s00105-019-4378-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"12 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.A.\u00a0Juratli, A.\u00a0G\u00f6r\u00f6g und M.\u00a0S\u00e1rdy geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}